Analytical Data
-
Gene name
USP53
- Application
-
Alternative Names
USP53; KIAA1350; Inactive ubiquitin carboxyl-terminal hydrolase 53; Inactive ubiquitin-specific peptidase 53
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q70EK8
-
Expression Region
1-188 aa
-
AA Sequence
MDQCYFENSLSTECIIRSASRSDGCQMPKLFCQNLPPPLPPKKYAITSVPQSEKSESTPDVKLTEVFKATSHLPKHSLSTASEPSLEVSTHMNDERHKETFQVRECFGNTPNCPSSSSTNDFQANSGAIDAFCQPELDSISTCPNETVSLTTYFSVDSCMTDTYRLKYHQRPKLSFPESSGFCNNSLS
-
Molecular Weight
47.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
USP53, a member of the ubiquitin-specific protease family, has garnered significant attention in recent years due to its pivotal role in regulating various cellular processes through the modulation of protein ubiquitination. Ubiquitination is a post-translational modification that controls protein stability, localization, and activity, making deubiquitinating enzymes like USP53 essential in maintaining cellular homeostasis. Research has indicated that USP53 may be implicated in key biological functions, including cell proliferation, apoptosis, and stress responses, as well as in the pathogenesis of several diseases, including cancer and neurodegenerative disorders. The ability of USP53 to remove ubiquitin moieties from substrates positions it as a potential therapeutic target, with implications for the development of novel strategies in cancer therapy and other diseases. However, the specific substrates and molecular mechanisms through which USP53 exerts its effects remain largely unexplored. Recent advancements in recombinant protein expression technologies and proteomic analyses are paving the way for a deeper understanding of USP53's functions and interactions. By studying the recombinant USP53 protein, researchers aim to delineate its biochemical properties, identify its substrates, and elucidate its role in various signaling pathways, which could ultimately lead to innovative therapeutic approaches and enhance our understanding of cellular regulation in health and disease.











